Cargando…
Novel Systemic Therapies for Advanced Gastric Cancer
Gastric cancer (GC) is the second leading cause of cancer mortality and the fourth most commonly diagnosed malignant diseases. While continued efforts have been focused on GC treatment, the introduction of trastuzumab marked the beginning of a new era of target-specific treatments. Considering the d...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Gastric Cancer Association
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881006/ https://www.ncbi.nlm.nih.gov/pubmed/29629216 http://dx.doi.org/10.5230/jgc.2018.18.e3 |